Unusually long remission in two patients with follicular lymphoma receiving immunomodulating therapeutic cancer vaccines
Morten Orebo Holmström, Shamaila Munir Ahmad, Uffe Klausen, Mads Emil Bjørn, Anne Ortved Gang, Tarec Christoffer El-Galaly, Lars Møller Pedersen, Mads Hald Andersen · 2026
Read Unusually long remission in two patients with follicular lymphoma receiving immunomodulating therapeutic cancer vaccines by Morten Orebo Holmström, Shamaila Munir Ahmad, Uffe Klausen, Mads Emil Bjørn, Anne Ortved Gang, Tarec Christoffer El-Galaly, Lars Møller Pedersen, Mads Hald Andersen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13572160.txt.
Description
Morten Holmström and seven co-authors follow patients from an early vaccine trial for a slow-growing lymphoma, in a paper dated 2026. The cancer, follicular lymphoma, carries immune brake proteins on its surface, yet brake-blocking drugs have failed against it. The trial instead vaccinated patients to train their own immune cells against those brakes.
Eight patients took part, and two stand out. One had relapsed twice soon after diagnosis, then stayed free of treatment for five years after vaccination. The other remains in complete response six and a half years later, after entering the trial at a late treatment stage. Blood monitoring showed vaccine-trained immune cells stayed active and working over time. The cases hint that such vaccines can hold this cancer back for years.
Catalog record
| CREATOR | Morten Orebo Holmström, Shamaila Munir Ahmad, Uffe Klausen, Mads Emil Bjørn, Anne Ortved Gang, Tarec Christoffer El-Galaly, Lars Møller Pedersen, Mads Hald Andersen |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 19 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |